Video

Dr. Rapisuwon on the Frontline Treatment of Acral and Mucosal Melanoma

Suthee Rapisuwon, MD, discusses the frontline treatment of acral and mucosal melanoma.

Suthee Rapisuwon, MD, medical oncologist, MedStar Health, discusses the frontline treatment of acral and mucosal melanoma.

Immunotherapy is the preferred frontline treatment option for patients with acral and mucosal melanoma since the diseases often lack targetable mutations, says Rapisuwon. Data from the phase 3 CheckMate-067 trial demonstrated activity with ipilimumab (Yervoy) in combination with nivolumab (Opdivo) for patients with acral and mucosal melanoma. Although the efficacy was generally decreased in these subtypes compared with that in cutaneous melanoma, this is the preferred frontline regimen, Rapisuwon explains.

Future research efforts are aiming to identify novel combinations to treat these patient populations, Rapisuwon says. For example, Chinese investigators are looking into combining PD-1 inhibitors with VEGF inhibitors, such as axitinib (Inlyta). The goal of combination therapy is to provide patients with additional benefit compared with PD-1 inhibitors alone, Rapisuwon explains. However, more data are needed to establish the utility of combination therapy and move forward with other clinical trials, concludes Rapisuwon.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity